These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19653114)

  • 1. Clinical and metabolic risk factor evaluation in young adults with kidney stones.
    Spivacow FR; Negri AL; del Valle EE; Calviño I; Zanchetta JR
    Int Urol Nephrol; 2010 Jun; 42(2):471-5. PubMed ID: 19653114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic risk factors in children with kidney stone disease: an update.
    Spivacow FR; Del Valle EE; Boailchuk JA; Sandoval Díaz G; Rodríguez Ugarte V; Arreaga Álvarez Z
    Pediatr Nephrol; 2020 Nov; 35(11):2107-2112. PubMed ID: 32564280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic risk factors in children with kidney stone disease.
    Spivacow FR; Negri AL; del Valle EE; Calviño I; Fradinger E; Zanchetta JR
    Pediatr Nephrol; 2008 Jul; 23(7):1129-33. PubMed ID: 18324422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ability of a limited metabolic assessment to identify pediatric stone formers with metabolic abnormalities.
    Chan KH; Moser EA; Whittam BM; Misseri R; Cain MP; Krambeck A
    J Pediatr Urol; 2018 Aug; 14(4):331.e1-331.e6. PubMed ID: 30177386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stone growth patterns and risk for surgery among children presenting with hypercalciuria, hypocitraturia and cystinuria as underlying metabolic causes of urolithiasis.
    Zu'bi F; Sidler M; Harvey E; Lopes RI; Hojjat A; Naoum N; Pokarowski M; Lorenzo AJ; Farhat WA; Papanikolaou F; Dos Santos J
    J Pediatr Urol; 2017 Aug; 13(4):357.e1-357.e7. PubMed ID: 28865885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Metabolic Correlates of Calcium Oxalate Stone Subtypes: Implications for Etiology and Management.
    Bamberger JN; Blum KA; Kan KM; Parkhomenko E; Gallante B; Gupta M
    J Endourol; 2019 Sep; 33(9):755-760. PubMed ID: 31154910
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical diagnosis in 3040 kidney stone formers in Argentina.
    Spivacow FR; del Valle EE; Negri AL; Fradinger E; Abib A; Rey P
    Urolithiasis; 2015 Aug; 43(4):323-30. PubMed ID: 25958053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multiregional Italian cohort of 24-hour urine metabolic evaluation in renal stone formers.
    Esperto F; Marangella M; Trinchieri A; Petrarulo M; Miano R
    Minerva Urol Nefrol; 2018 Feb; 70(1):87-94. PubMed ID: 28882031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic evaluation of recurrent idiopathic calcium stone disease in Portugal].
    Serra A; Domingos F; Salgueiro C; Prata MM
    Acta Med Port; 2004; 17(1):27-34. PubMed ID: 15636725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of renal stone disease: metabolic study].
    Areses Trapote R; Urbieta Garagorri MA; Ubetagoyena Arrieta M; Mingo Monge T; Arruebarrena Lizarraga D
    An Pediatr (Barc); 2004 Nov; 61(5):418-27. PubMed ID: 15530322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
    Huynh LM; Dianatnejad S; Tofani S; Carrillo Ceja R; Liang K; Tapiero S; Jiang P; Youssef RF
    Scand J Urol; 2020 Dec; 54(6):456-462. PubMed ID: 33185135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic changes in 2612 patients with nephrolithiasis].
    del Valle E; Spivacow R; Zanchetta JR
    Medicina (B Aires); 1999; 59(5 Pt 1):417-22. PubMed ID: 10684159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic risk factors in children with asymptomatic hematuria.
    Spivacow FR; Del Valle EE; Rey PG
    Pediatr Nephrol; 2016 Jul; 31(7):1101-6. PubMed ID: 26913725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Modern Metabolic Stone Evaluation in Children.
    Bevill M; Kattula A; Cooper CS; Storm DW
    Urology; 2017 Mar; 101():15-20. PubMed ID: 27838366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of paediatric renal stone disease: a 22-year single centre experience in the UK.
    Issler N; Dufek S; Kleta R; Bockenhauer D; Smeulders N; Van't Hoff W
    BMC Nephrol; 2017 Apr; 18(1):136. PubMed ID: 28420322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic diagnosis.].
    Mainez JA; Quintana LM; Cansino R
    Arch Esp Urol; 2021 Jan; 74(1):49-61. PubMed ID: 33459621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic evaluation of patients with recurrent idiopathic calcium nephrolithiasis.
    Hess B; Hasler-Strub U; Ackermann D; Jaeger P
    Nephrol Dial Transplant; 1997 Jul; 12(7):1362-8. PubMed ID: 9249770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic abnormalities associated with renal calculi in patients with horseshoe kidneys.
    Raj GV; Auge BK; Assimos D; Preminger GM
    J Endourol; 2004 Mar; 18(2):157-61. PubMed ID: 15072623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors.
    Caudarella R; Vescini F; Buffa A; Sinicropi G; Rizzoli E; La Manna G; Stefoni S
    J Nephrol; 2003; 16(2):260-6. PubMed ID: 12768074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.